glp-1 kidney side effects Glucagon-like Peptide-1 Receptor Agonists and Diabetic Disease: From Bench to Bed-Side Kidney Outcomes With Glucagon-Like Peptide-1

GLP-1 triggers the release of insulin from your pancreas

2022;34:105463.e7

Although the sample size was small with only 48 total participants randomized across the two treatment conditions, the randomized, double-blinded, experimental design provides some compelling preliminary evidence that semaglutide might reduce alcohol craving and the amount of alcohol consumed on drinking days in people with alcohol use disorder not actively seeking treatment

Taking Januvia with other drugs Januvia is used to treat type 2 diabetes

One study found that 90% of individuals experienced adverse side effects in the first eight weeks of treatment, while another study found that 70% of diabetes patients discontinued use after 2 years due to feeling chronically sick